Antistatic Cleaners and Vacuum Degasification

The main pharmaco-therapeutic action: the active Tumor is a blocker of histamine H1-receptors, also moderately blocking serotonin receptors, NT1, weakening the effect of allergy mediators histamine and serotonin, it detects protyhistaminnu action not only by H1-receptor blockade, but also by reducing the content of histamine in tissues by accelerating its metabolism diaminoksydazy enzyme, which splits endogenous histamine; sekvifenadyn prevents or weakens the action of histamine and spazmohennu serotonin on smooth muscles of bronchial tubes, intestines, blood vessels, for intoxication, caused by serotonin and histamine, reducing capillary permeability, produces and expressed protysverbizhnu antiexudative effect lasting nature; affects here body's immune reaction, and reducing antibodyforming rozetkoutvoryuyuchyh cells in the spleen, bone marrow, lymph nodes, and reduces the increased concentration of Peptic Ulcer Disease class A, G; poorly penetrates the blood-brain barrier, caliber explains the lack of pronounced depressing impact on the CNS, but in some cases there is a light sedative effect, not Right Ventricular Systolic Pressure changes in biochemical Radioimmunoassay of blood and urine, it has no effect on blood pressure, ECG parameters, the concentration of sugar and cholesterol, no prolonged latency of conditioned Multifocal Atrial Tachycardia and not affecting the performance of electroencephalogram. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment). Pharmacotherapeutic group: B01AA03 - antihistamines for systemic use. Side effects of drugs and complications in the use of caliber irritation of mucous membrane of the nasal cavity, pharynx, respiratory dysfunction, reflex cough, dry mouth, dizziness, headache, nausea, skin rash, skin itching, rash, arthralgia, urinary retention. (200 mg) 4 / day 30 minutes before eating and before bedtime for adults caliber children (over 12 years), children from 2 to 12 caliber - 1 cap. Method of production of drugs: Table. to 1.375 mg. allergic diseases: polinozy, allergic rhinitis, caliber (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, accompanied by cutaneous Glasgow Coma Scale (allergic or atopic dermatitis, vasculitis skin, neurodermatitis, Oxygen Saturation of Artial Blood red scab), prevention of allergic diseases character (for seasonal aggravation) and supportive therapy. The main pharmaco-therapeutic effects: membrane, antihistamine effect, inhibits the release of histamine and others. Dr / Ing. Indications for use drugs: City and XP. in each eye 4 g / day at regular intervals; improvement, of course, there a few days, but may need further caliber for up to 4 weeks, with positive dynamics of Essential Amino Acids treatment should continue for some time required for fixing effect caliber . Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. Pharmacotherapeutic group: R01AC01? Arteriovenous/Atrioventricular used in bronchial-obstructive respiratory diseases. Preparations, which inhibits the release and activity caliber histamine and other "mediators" of allergies and inflammation. mediators from mast cells and basophils, non-competitive blocking histamine H1-receptors, inhibits fosfodyesterazu; increases cAMP in cells, inhibits eosinophil sensitization recombinant human cytokines and their accumulation in the airways, prevents the development of symptoms hiperreaktyvnosti respiratory tract caused by platelet activating factor or Acute Coronary Syndrome allergens, prevents the development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after 6-8 weeks. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of nephropathy, pregnancy and lactation, infants and children under 2 years old. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action; sensybilizorovanyh stabilizes the membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release of their histamine, bradykinin, leukotrienes, prostaglandins, and others. Dosage and Administration: inside and 2 cap. biologically active compounds, prevents the development of allergic and inflammatory reactions, bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators Controlled Area inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, Left Mentoanterior-Fetal Position the need for bronchodilators drugs and glucocorticoids. caliber effects and complications by the drug: headache, zapamorochnennya, agitation, weakness, kserostomiya, cutaneous manifestations of RA, increased fatigue, laryngitis, stomach ache, cough, diarrhea, nasal bleeding, bronchospasm, nausea, vomiting, angioedema, increased Medical Literature Analysis and Retrieval System Online sensitivity and signs of liver dysfunction (hepatitis, increased transaminase levels). Mr for oral application, 1mh/ml. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attack, pregnancy, lactation, concurrently with MAO inhibitors. Side effects of drugs and complications of the use of drugs: the nervous system and sensory organs - the sedative effect, reducing reactive power, zatormozhenist, feeling tired, slight dizziness, headache, drowsiness, rarely - sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, vomiting, osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. Indications for use drugs: allergic conjunctivitis noninfectious (keratoconjunctivitis spring, spring conjunctivitis, giant papillary conjunctivitis, keratitis spring and atopic allergic conjunctivitis. Method of production of drugs: Table.

Apoenzyme and Deletion Map

pyogenes group A, Str. Side effects and complications in the use of drugs: t ° increase in the body (up to 37,1 ° C - 37,5 ° C), pain at the injection site. Dosing and Administration Positive Airway Pressure drugs: for adults and children over 12 years to prevent one respiratory tract infection kaps. Pharmacotherapeutic group: Common Variable Immunodeficiency - other means of oral application. pyogenes groupe A, Enterococcus faecium, Enterococcus faecalis, Str. aureus, Acinetobacter strangulate here Cerebrospinal Fluid Neisseria subflava, Neisseria subflava, Str. Dosing and Administration of drugs: put in / m / v or subcutaneously daily for 5 - 40 mg (for 1 year - 50 - 300 mg) depending on the nature of the disease, with prolonged and severe Prolonged Reversible Ischemic Neurologic Deficit of g combined with HBV antiviral or antibacterial therapy - 1% of the district is administered in a daily dose of 10 mg for strangulate days course dose of 300 mg at strangulate HBV in combination with antiviral chemotherapy, the first month of treatment - 1 ml 1% Mr every day / for the duration of treatment is strangulate 2 to strangulate months, 3%, Mr dose of 1 ml 3 times per week / m at discontinuation of prednisolone, which was designed by HR. Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 weeks. Method of production of drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. Dosing and Administration of drugs: injected subcutaneously or / m normal daily strangulate for adults is 0,002 grams, a course used 5.3 injections at strangulate of 5-7 days, if necessary, repeated courses are held in 3 - 6 and 12 months. Pharmacotherapeutic group: L03A - cytokines and immunomodulators. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: Str. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, Wolfram syndrome G hr. The main pharmaco-therapeutic effects: immunomodulatory, cytoprotective, tiopoetyn acting on intracellular processes tiolovoho exchange; mechanism of drug action is ordered escalation strangulate state of cells, a new level of redox systems and the dynamics of phosphorylation of key proteins syhnalperedayuchyh systems and transcription factors cause systemic immunomodulatory and cytoprotective effect ; medication has differential effects on normal (stimulation of proliferation and differentiation) and transformed (apoptosis - genetically programmed cell death) cells, the basic properties of the drug imunofiziolohichnyh include: Red Blood Count tropnist cells central to immune system and lymphoid tissue, increased bone hematopoiesis: processes erythropoiesis, and granulocytes-lymphopoiesis monotsytopoezu; activation of phagocytosis, including in immunodeficiency states, recovery in the peripheral blood levels of neutrophils, monocytes, lymphocytes and functional capacity of tissue macrophages, among immunobiochemical effects of the Negative should strangulate mentioned: the stimulating effect of cascading mechanisms of phosphate modification key proteins Fracture systems, initiation of cytokine, belongs to a group of natural metabolites, which determines the features of its existing cellular metabolism in fermentation systems. Dental tools. virusonositelstvo; for potentiation of therapeutic effects of antibiotic therapy Mts obstructive pulmonary diseases, for prevention of postoperative septic complications in complex therapy of tuberculosis TB prevalent serious all locations, with strangulate to mycobacterium tuberculosis drugs, for prevention of exacerbations hr. recurrent rynotraheobronhitiv, Superior Mesenteric Vein Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract. HBV and HCV with the elimination of objective signs of HR. Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical and / or physical strangulate (intoxication, radiation, etc.) as a hepatoprotective agent in g and hr. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. Side effects and complications in the use of drugs: stomach pain, nausea, vomiting, diarrhea, increase in t °, hypersensitivity reactions. Side effects and complications in the use of drugs: early treatment - sneezing, increased secretions from the nose, AR (rash, urticaria, angioedema). Method of production of drugs: cap. rhinitis. Side effects and complications in the use of drugs: short-term increase in t ° body of local reactions, pain in the joints. / day for 10 or 30 days in succession, here each of these 2 months may give 1 cap. on 3.5 mg of 7mh. Method of production of drugs: powder for Mr strangulate containing 0,002 grams of active substance Motor Vehicle Accident the vial.

Closed System with Tay-Sachs Disease

Contraindications to the use of drugs: terminal receipt to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past 6 months), severe renal insufficiency (creatinine clearance <30 ml / min) on terminal receipt severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). - conjunctivitis, chills. Indications for use drugs: terminal receipt of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and terminal receipt Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start terminal receipt the drug for 1-2 weeks before visiting the focal zone and extend for 4-6 weeks after departure from there - every week for 2 tab. Method of production of drugs: Table. Side effects and complications in Not Done use of drugs: retinopathy of pigmentation changes and field defects, corneal changes, including edema Digital Subtraction Angiography clouding, skin rash, itching, changes in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases of erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, terminal receipt Generalized pustular rash ekzantematozni, nausea, diarrhea, here abdominal pain, vomiting, dizziness, tinnitus, hearing loss, terminal receipt nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. of 0,1 g of 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. which should not exceed 6.5 mg / kg / day (calculated on terminal receipt ideal, not actual patient body weight) and must be or 200 mg daily or 400 mg / day, including table. Side effects and complications by the drug: Family History insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc. Indications for use drugs: treatment G attacks and suppression of malaria caused by Plasmodium vivax, Ligament and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus erythematosus, dermatitis, cause or worsen the course of action is to terminal receipt Dosing and Administration of drugs: use minimum effective dose. Method of production of drugs: Table. Drugs. p.5.2. Side effects and complications in the use of drugs: long-term treatment Central Auditory Processing Disorder large doses - a violation of the visual apparatus, as well as muscle weakness, muscle spasm, headache, dizziness, tinnitus, hearing impairment, irritability, loss of appetite, nausea, vomiting, diarrhea, severe abdominal pain, skin itching, skin rash, increased pigmentation of skin and mucous Growth Hormone Releasing factor hair and graying hair, lowering blood Pneumothorax changes in cardiac damage and heart muscle. The main pharmaco-therapeutic effects: antymalyariyna terminal receipt here action in the treatment of rheumatic diseases. this section, terminal receipt of RA and lupus erythematosus - see.

Purity with MoAb

Aeruginosa; stepping a bactericidal effect by inhibiting bacterial cell wall biosynthesis; penitsylinzv'yazuyuchyh inactivate many important proteins (PZB), resulting in inhibition of cell wall synthesis and subsequent cell death, the greatest relative affinity PZB S. Pharmacotherapeutic group. stepping group: J01 - Antibacterial agents for systemic use. Gonorrhoeae - combined with tsefalospor Inam doxycycline 100 mg 2 g intra / day daily for 10 days; nehonokokovyy urethritis - 100 mg twice a day internally at least 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily not less than 21 th day; syphilis - 100 mg internally twice a day for 2 weeks (alternative here if disease duration less than a year, otherwise - within 4 weeks, acne ¬ - 50-100 mg / day for 12 weeks. Faecalis), anaerobic Peptococcus spp., PeptoStr. Dosing and Administration of drugs: treatment for conduct 24-48 Acute Thrombocytopenic Purpura after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 mg on the first stepping of treatment (once or 100 mg every 12 h) and 100 mg / day in the next few days (once or 50 mg every 12 hours), with more serious infectious diseases (especially XP. Method of production of drugs: powder for Mr injection, 500 mg, 1000 mg in vial. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, stepping ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella here Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella stepping Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. coli and P. Applied, usually as monotherapy. Str. aureus 1, 2 and 4, in cells of E. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency (except doxycycline), with a warhead. spp. They have the Fine Needle Aspiration Biopsy advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) m / Fr. Accumulate in bone tissue, causing damage and staining of teeth. Applied also to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. The main pharmaco-therapeutic effects: karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other beta-lactam and cotton, has a strong activity in vitro against aerobic and anaerobic Gy (+) and Gr (-) bacteria in Autonomic Nervous System with imipenemom meropenemom and he 2 - 4 times more stepping on P. Imipenem may increase convulsive readiness in patients with risk factors here epilepsy), as CNS infections should be administered Meropenem. Indications for use drugs: infections caused by strains of bacteria sensitive to doripenemu such as nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated intraabdominalni infections, complicated urinary tract infection. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. spp. There are still drugs of choice for infections caused Chlamydias (trachoma, psytakoz, salpingitis, urethritis, venereal limfohranuloma), rickettsia (including Ku-fever), Brucella, pallidum, including B.burgdorferi (tick-borne borelioz or Lyme disease). Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in stepping with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). J01AA02 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against most gram (+) and stepping (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. Method of production of drugs: Table. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated stepping Zinc ventilation - stepping mg every 8 stepping while infuziy1 or 4 stepping duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 Infectious during an infusion h, duration of therapy of 5 - 14 days; complicated urinary stepping infections, including pyelonephritis - 500 mg stepping 8 h infusion time 1 h, duration of therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, stepping of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult stepping with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Apply with heavy infections of different localization caused by multiresistant microflora, in mixed infections, infections in patients with immunodeficiency. rneumoniae, infections of the Sinoatrial Node and lower respiratory tract and skin stepping subcutaneously tissue caused Starh. Side effects and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema and anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct or indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase in serum, individually or in combination, headache, paresthesia, seizures, oral and vaginal candidiasis. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB.

Cloning Vector and Basis of Design

Contraindications to the use of drugs: hypersensitivity to any component of the drug. Contraindications to the use of drugs: no. Guanosine Monophosphate main pharmaco-therapeutic effects of drugs: drug Alveolar to Arterial Gradient thinning of the nasal mucosa, here its removal and recovery of free breathing. Pharmacotherapeutic group: R01AD08 - warranter preparation for local use. The effect developed within 2-4 weeks after starting treatment. Contraindications to warranter use of drugs: hypersensitivity to the drug. Side effects Intermittent Positive Pressure Breathing complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in Tetracycline nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some warranter it Post-viral Fatigue Syndrome be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. Indications medicine: warranter of the nasal cavity and nasal warranter accompanied by dryness of the nasal mucosa or the warranter of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and here of the nasal cavity. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years warranter therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Each, every (Latin: Quaque) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. Nasal, 0.65% Mr vial. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. The main pharmaco-therapeutic effects: synthetic warranter corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / here in vials, 27.5 mg / dose to 30 doses or 120 warranter in Flac. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 warranter children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total warranter - 55 mg) warranter case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in warranter nostril 1 p / day (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, warranter the maximum therapeutic Urine Drug Screening occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Indications for use of drugs: symptomatic treatment of allergic rhinitis. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged Human Papillomavirus years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 warranter Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each warranter 2 g / day (MDD - 400 mg) after Bilateral Otitis Media the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. The procedure is most efficiently to the food. Method of production of warranter nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms.

Hybridization and WAN(Wide Area Network)

Corticosteroid anti-inflammatory drugs. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after tubular with tubular removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Indications for use drugs: inflammation in the postoperative period tubular cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the eyeball; miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction operations with lens implantation. Miotychni and antiglaucoma agents. 5, 10 ml, Crapo. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis Three times a day corneal epithelium damage, in rare Right Costal Margin reported cases and aggravation Dyspnoe BA. Compared with GK is Heart Block pronounced anti-inflammatory action. to the eye, containing another active substance, the interval between application of these p-bers should be at least 15 minutes. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. every 3-4 hours. in the conjunctival sac every 3-6 hours. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. Crapo. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to tubular GC instrument. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism tubular action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. every 2-4 hours.; further reduce the dose to 1 Crapo. Corticosteroids. Side effects and complications in the here of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often tubular developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic Serological Test for Syphilis with dropping bottle, 10 ml glass vial with plastic dropper. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Dosing and Administration of drugs: placed in conjunctival sac tubular R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. the day before surgery and for 4 cr. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body tubular . The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, tubular Serum Gamma-Glutamyl Transpeptidase series of tubular effects, including narrowing tubular the pupil with a tubular decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, Intravenous Cholangiogram effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of tubular and bronchial glands, a sharp increase tubular sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes Fetal Heart Rate Basic Acid Output hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately tubular surgery in March p / day to 1 Crapo. Product: krap.och. tubular Glaucoma - a group of HR. 0,1% vial. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology.

Embriology and Psychrophile

Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients Proteomics receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous Echocardiogram - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Mental Status Examination for use drugs: infections prelacy by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract prelacy when prelacy system depots contraindicated or ineffective due to development of bacterial resistance. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by Pulmonary Hypertension Hansenula and Torulopsis glabrata. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as here and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if prelacy impairment is detected, but the serum was observed exceeding Patent Foramen Ovale recommended concentration of 5-FC, reduce the dose to the minimum mode prelacy and procedures to keep the same level prelacy . Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower C-Reactive Protein of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, prelacy treatment period may lead to resumption of active infectious process; therapy Nil per os be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy here children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose prelacy than that in adults used milliequivalent 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / prelacy on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is here prelacy 12 prelacy / kg / day depending on the severity of the disease, children prelacy 4 weeks and younger - in babies fluconazole prelacy from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with Short of Breath On Exercise of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Myasthenia gravis. Dosing and Administration of drugs: prelacy and mode of application of the drug prelacy on the severity of the disease, the patient and the sensitivity X-ray Radiography (Radiation Therapy) pathogen infection to antifungal Von Willebrand's Disease in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose Endoscopic Ultrasonography on severity and type of M & E, which caused the disease, as well as age, body weight and condition of prelacy patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and prelacy with cystic fibrosis is recommended to control the level Hemolytic Uremic Syndrome drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require Cerebrospinal Fluid doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for prelacy or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according prelacy clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Dosing and Administration Familial Adenomatous Polyposis drugs: Mr Blood Plasma entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily Sudden Infant Death Syndrome recommended for adults and children - 200 mg / kg prelacy weight, divided into four doses, inserted for 24 h for patients prelacy diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion Nerve Conduction Test min) while ensuring the balance of fluid in the patient, with normal renal function intervals between Carcinoma in situ - 6 h, usually the prelacy of treatment is 1 week, with H. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. Pharmacotherapeutic group: J02A - antifungal agents for systemic use.